Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines
- PMID: 1638534
Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines
Abstract
In an effort to analyze molecular mechanisms of human ovarian carcinogenesis, we studied the structure and expression of the p53 gene in different cell lines established from human ovarian carcinomas. In all six lines (PA-1, Caov-3 and -4, OVCAR-3, SK-OV-3, and Kuramochi), p53 abnormalities were detected. In the SK-OV-3 cell line, Southern analysis suggested the presence of sequence deletions/rearrangements in at least one allele of the p53 gene, and transcripts were not detectable by either Northern or polymerase chain reaction analysis. Sequence analysis of the entire coding region of the p53 gene revealed point mutations resulting in codon changes of a highly conserved region of the protein in four cell lines, Caov-3 and -4, OVCAR-3, and Kuramochi. In the Caov-3 cell line, the point mutation resulted in chain termination at codon 136. Quantitation of p53 protein by immunoprecipitation analysis revealed a 6-fold higher than control cell level in PA-1. By contrast, p53 protein was not detectable in lines Caov-3 and SK-OV-3. We conclude that altered levels of p53 gene expression and/or mutant forms of the p53 gene product are associated with all human ovarian cancer cells tested.
Similar articles
-
Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.Exp Cell Res. 1997 Jun 15;233(2):233-9. doi: 10.1006/excr.1997.3560. Exp Cell Res. 1997. PMID: 9194486
-
[Analysis of p53 gene in gynecologic tumors].Rinsho Byori. 1994 Mar;42(3):235-41. Rinsho Byori. 1994. PMID: 8152158 Japanese.
-
p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.Cancer Res. 1991 Nov 1;51(21):5800-5. Cancer Res. 1991. PMID: 1933850
-
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.Cancer Res. 1996 Feb 1;56(3):556-62. Cancer Res. 1996. PMID: 8564971
-
p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines.Gynecol Oncol. 1996 Jan;60(1):72-80. doi: 10.1006/gyno.1996.0014. Gynecol Oncol. 1996. PMID: 8557231
Cited by
-
Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer.Int J Mol Sci. 2021 May 26;22(11):5681. doi: 10.3390/ijms22115681. Int J Mol Sci. 2021. PMID: 34073600 Free PMC article. Review.
-
A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin.Br J Cancer. 2004 Mar 22;90(6):1285-92. doi: 10.1038/sj.bjc.6601653. Br J Cancer. 2004. PMID: 15026814 Free PMC article.
-
Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.J Gynecol Oncol. 2009 Mar;20(1):48-54. doi: 10.3802/jgo.2009.20.1.48. Epub 2009 Mar 31. J Gynecol Oncol. 2009. PMID: 19471670 Free PMC article.
-
Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells.Cancer Lett. 2015 Jan 28;356(2 Pt B):418-33. doi: 10.1016/j.canlet.2014.09.023. Epub 2014 Oct 7. Cancer Lett. 2015. PMID: 25304379 Free PMC article.
-
The nucleoside analog clitocine is a potent and efficacious readthrough agent.RNA. 2017 Apr;23(4):567-577. doi: 10.1261/rna.060236.116. Epub 2017 Jan 17. RNA. 2017. PMID: 28096517 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous